[Staff vaccination with a new subunit influenza vaccine].
D000914:Antibodies, Viral / Q000032:analysis*; D006385:Hemagglutination Inhibition Tests; D006388:Hemagglutinins / Q000032:analysis; D006801:Humans; D007252:Influenza Vaccines / Q000009:adverse effects / Q000032:analysis / Q000627:therapeutic use*; D007273:Injections, Intramuscular; D007277:Injections, Jet; D009439:Neuraminidase / Q000032:analysis; D009787:Occupational Medicine
D000914:Antibodies, Viral; D006388:Hemagglutinins; D007252:Influenza Vaccines; D009439:Neuraminidase
Betriebsimpfung mit einem neuen Influenza-Subunitimpfstoff.